University of Canterbury entrants win all three HealthTech Awards for Best Research miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Date Time
Nutromics wins best early-stage project award
Nutromics took home the coverted ‘Best Translational Research’ award at AusMedtech 2021’s Early-Stage Investment Forum, after winning the pitching event judged by an expert investment panel.
Nutromics’ Head of Commercial and Intellectual Property Ms Rosie Stramandinoli presented the company’s wearable Continuous Molecular Monitoring (CMM) platform which can measure a wide array of molecular targets continuously and in real time, including drugs, hormones, metabolites, and proteins. This platform technology enables clinicians to receive continuous real-time molecular data to accurately dose a patient and keep them within a narrow therapeutic range. Nutromics’ vision is to create a world with zero preventable deaths due to the lack of timely, molecular-level data.
Date Time
Investment support for early-stage translation
Feedback essential for commercialising early-stage projects and technologies is being offered by an expert and investor group at AusMedtech’s Early Stage Investment Forum. Early-stage projects are invited to apply for the AusMedtech 2021 Early Stage Investment Forum, with submissions due 9 April 2021.
The Forum offers six-minute virtual quick-pitches to an expert investor panel that will include international big pharma representatives, corporate VCs and early-stage investors. Each presentation will be followed by direct feedback that will be valuable during translation and commercialisation.
In an exciting new development, the Forum is being held for the first time at AusMedtech 2021, Australia’s premier medtech event, and will be supported by Medtronic. The Forum will take place on Friday 21 May.